New Zealand Pharmaceuticals (NZP)
About Us
"New Zealand Pharmaceuticals Ltd was established in 1971 to extract and purify biochemicals from by-products of the New Zealand meat processing industry. The company's first products were pharmaceutical intermediates extracted from bovine or ovine bile. Over the next 15 years NZP's reputation for quality and service allowed it to become one of the major manufacturers and suppliers of these products to the market. The product range broadened to include a variety of other biochemicals from the meat industry.
The acquisition of Dextra Laboratories in 2009 extended NZP's offering to the market. Dextra's primary area of expertise is the design and synthesis of complex carbohydrates and derivatives, with extensive know-how and patents in a number of areas; most notably its blood group antigen products."
